Benefit

Strongest Product Associations and # of Responses

Miconazole efficacy

M1: 983 (41%), M3: 1994 (41%), M7: 2940 (46%)

Total: 5917 (43%)

4 x faster relief

M1: 761 (32%), M3: 1545 (31%), M7: 1641 (26%),

Tio1: 2556 (45%)

Total: 6503 (34%)

Safer vs. oral Rx

M1: 324 (13%), M3: 1145 (23%), M7: 1721 (27%),

Tio1: 1631 (29%)

Total: 4821 (25%)

Patient prefers less mess ovule

M1: 1049 (44%), M3: 1276 (26%) Total: 2325 (32%)

Women on OCs & oral anti-diabetics + other drugs

M1: 450 (19%), M3: 851 (17%), M7: 617 (10%),

Tio1: 1467 (26%)

Total: 3385 (18%)

Resistance of oral fluconazole increasing

M1: 380 (16%), M3: 654 (13%), M7: 681 (11%),

Tio1: 797 (14%)

Total: 2512 (13%)

Patient failed on fluconazole

M1: 477 (20%), M3: 507 (10%), M7: 828 (13%),

Tio1: 728 (13%)

Total: 2540 (13%)

Preferred longer duration

M7: 3618 (57%)

Safe in pregnancy

M7: 3025 (47%)